CVS
43
2
MCK
73
2
REGN
65
2
PBI
58
8
HES
68
2
MU
56
-3
CAT
69
3
ADP
68
2
AFL
66
2
CMG
70
-2
ILMN
23
-5
PLD
58
10
VIX
11
-2
BRK.B
47
2
QRVO
34
-4
SBUX
36
4
EMC
85
38
EBAY
43
-2
FFIV
64
2
HAL
50
4
CVS
43
2
MCK
73
2
REGN
65
2
PBI
58
8
HES
68
2
MU
56
-3
CAT
69
3
ADP
68
2
AFL
66
2
CMG
70
-2
ILMN
23
-5
PLD
58
10
VIX
11
-2
BRK.B
47
2
QRVO
34
-4
SBUX
36
4
EMC
85
38
EBAY
43
-2
FFIV
64
2
HAL
50
4
Financhill
Back

Heron Therapeutics 10K Form

Sell
48

HRTX
Heron Therapeutics

Last Price:
3.20
Seasonality Move:
3.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HRTX News And Ratings

See the #1 stock for the next 7 days that we like better than HRTX

HRTX Financial Statistics

Sales & Book Value

Annual Sales: $127.04M
Cash Flow: $-9.52M
Price / Cash Flow: 0
Annual Sales: $-0.22
Price / Book: 0

Profitability

EPS (TTM): -0.59000
Net Income (TTM): $-80.95M
Gross Margin: $61.94M
Return on Equity: 0%
Return on Assets: -37.08%

Heron Therapeutics Earnings Forecast

Key Heron Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 37 years for HRTX is 48.75%.
  • The Selling, General & Administrative Expenses for HRTX have been equal to 91.82% of Gross Profit Margin.
  • The Research & Development expenses have been 44.00% of Revenue.
  • The Interest Expense is -3.50% of Operating Income.
  • The Net Earning history of HRTX is -87.02% of Total Revenues.
  • Per Share Earnings over the last 37 years have been positive in 20 years.

Heron Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: HRTX
CUSIP: 427746
Website: herontx.com

Debt

Debt-to-Equity Ratio: -5.15
Current Ratio: 2.47
Quick Ratio: 1.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

HRTX Technical Analysis vs Fundamental Analysis

Sell
48
Heron Therapeutics (HRTX) is a Sell

Is Heron Therapeutics a Buy or a Sell?